UCB Q1 2026 Earnings Modest EPS Miss in a Quarter of Steady Performance MeiraGTx Q1 2026 Earnings WiderThanExpected Loss Amid PreRevenue Pipeline Progress TransCode Therapeutics Q4 2024 Earnings Deep Losses Reflect PreRevenue Stage EPSN Q1 2026 Earnings Positive EPS Reported Despite Minimal Disclosure Sealed Air Q4 2025 Earnings Earnings Beat Expectations with EPS of 077 QFIN Q4 2025 Earnings EPS Misses Estimates Shares Slide 518